Publications by authors named "Kalle Savolainen"

Article Synopsis
  • * In a study involving 264 plasma samples from 63 EOC patients, ctDNA was found in 93% of samples at diagnosis and 100% at disease progression, indicating its effectiveness for monitoring.
  • * Positive ctDNA results after treatment correlated with faster disease progression and lower survival rates, and in some cases, ctDNA detected recurrence earlier than traditional methods by an average of 5.9 months.
View Article and Find Full Text PDF

Objective: Plasma, but also urine sample could represent a simple liquid biopsy for ovarian cancer biomarker detection. The miRNA-200 family has been shown to be dysregulated in ovarian cancer. The aim of this study was to isolate three members of miR-200 family from tumor tissue, plasma and urine of high-grade serous ovarian cancer patients in comparison with samples from patients with benign ovarian tumors.

View Article and Find Full Text PDF

Background: The composition of the matrix molecules is important in in vitro cell culture experiments of e.g. human cancer invasion and vessel formation.

View Article and Find Full Text PDF

Alpha-methylacyl-CoA racemase (Amacr) catalyzes the racemization of alpha-methyl-branched CoA esters. Sequence comparisons have shown that this enzyme is a member of the family III CoA transferases. The mammalian Amacr is involved in bile acid synthesis and branched-chain fatty acid degradation.

View Article and Find Full Text PDF

alpha-Methylacyl-CoA racemase (Amacr) deficiency in humans leads to sensory motor neuronal and liver abnormalities. The disorder is recessively inherited and caused by mutations in the AMACR gene, which encodes Amacr, an enzyme presumed to be essential for bile acid synthesis and to participate in the degradation of methyl-branched fatty acids. To generate a model to study the pathophysiology in Amacr deficiency we inactivated the mouse Amacr gene.

View Article and Find Full Text PDF